Π. Ζαρογουλίδης-Γ.Κουτέπας: Το Φαρμακείο ως επιχείρηση...

Preview:

Citation preview

PowerPoint Presentation

: & & Marketing .

, MBA . .

1 .

, , .. .12 ; 5 ; , , , . . .

1/3 470 , 1 5 . - ;- 2/3! , 60% , 50% , , . , , , . Kapa Research- : . 16-10-2014 www.in.gr

: & 334

. . . .

: &

556 -

7 , .

.

.

.

8 -

9 (- )= (- )(- )(- )=

(-) - : &

10

: &

11Pharma Reports

: &

12

(, , , )

: &

1313

: &

1415

16

17

( )

18

(!!! )

19

=

(, , , ) (Break Even Point)

: &

2020

21Break Even Point : ( ), , .

, (break even point), .

, , .

=

22 &

, : &

23 &

: &

24 .

(, , , ) (Break Even Point) , ,

: &

2525 (Cash Flow) () 5.000,00 7.000,00 1.200,00 9.000,00 9.000,00 () 10.000,00 11.500,00 5.000,00 15.000,00 13.000,00 15.000,00 18.500,00 6.200,00 24.000,00 22.000,00 11.538,46 14.230,77 4.769,23 18.461,54 16.923,08 2.000,00 800,00 700,00 1.400,00 1.200,00 16001600160016001600 15.138,46 16.630,77 7.069,23 21.461,54 19.723,08 - 138,46 1.869,23 - 869,23 2.538,46 2.276,92 15.000,00 14.861,54 16.730,77 15.861,54 18.400,00 - 138,46 1.869,23 - 869,23 2.538,46 2.276,92 14.861,54 16.730,77 15.861,54 18.400,00 20.676,92 : &

26

(, , , ) (Break Even Point) , ,

: &

2727 ... =( 365) : &

28

: &

2930 . ( ) .

,

( )

31 . .

.

32 /

=

33 =

34 .(- )= (- )(- )(- )=

35 * (- * )= (- )(- )(- )=

36 (. , , )

37 . 10 ... 13 25% 24 () 15% 6 () 12 /3 () 7,5 * 24 = 180 13 * 24 = 312 = 312-180=132 = 42,3% 132/180 = 73,3%() 8,5*6*4 = 204 13 * 24 = 312 = 312-204=108 = 34,6% 108/51 = 211.7% () >?< () 129 ?-> 24

38 . 20 ... 26 25% 24 () 15% 6 () 12 /3 () 15 * 24 = 360 26 * 24 = 624 = 624-360=264 264/360 = 73,3%

() 17 *6 *4 = 408 26 * 24 = 624 = 624-408=216 216/102 = 211,7% () >?< () 258 ?-> 48

39

1+2+..+ =

40 () 10% ; . 20 ... 26 25% 24 () 15% 6 () () 15 /3 (23,4) ->10% () 9 / 3 (24,7) ->5% () 15 * 30 = 450 23,4 * 30 = 702 = 702-450=252 = 35,9% 252/450 = 56%

() 17 *6 *3 = 306 24,7 * 18 = 444,6 = 444,6-306=138,6 = 31,1% 138,6/102 = 135,8% () >?< () 348 ?-> -12 ->-77.4 () !!! -> 113.4

41

.

, , ,

42 : ,

, .

43

!

44

-> -> ; = P*QP2*Q2 >?< P1*Q1 ;. 15 *10 >?< 12 *12 14?

45 C tabeff 5 .() 30 30%() 6 10%() 6 8 () 6 10 (+) (+)(+) 30 * 3,5 = 105 30 * 6 = 180 180 105 = 75 = 75/180 = 41% = 75/105 = 71,42%(+) 6 * 4,5 = 27 18 * 8 = 144 144 (3 * 27) = 63 = 63/144 = 43,75% = 63/27 = 233%

( + ) : 105 -> 75( + ) : 27 -> 63

46 . . , . !!

47 . ( ) ( ) !

48 (- )=

- - - = - = P1*Q1 + P2 * Q2 + P *Q(p1 * q1 + . + p * q)=

(, , )( + )(, )( )= - (, , )

1,944 20141,959 20151,945 2016-2018

49 Delloite 2015 2015 . .

.

50 2050 37% 60

86% 60% 65 75%

700

9% 14% .., 2/3 .

http://www.abbvie.com/content/dam/abbviecorp/us/desktop/sustainablehealthcare/images/EU-Call-To-Action.pdf

51

52

2015. , , .

, , .

, , . .

53

54 ( -) ,

, -

&

generics (, , )

,

55

56

57

.

.

, , ,

5859

60 ( ;) !! ;

61

62 ; ; ; ; ;

63 ; .

.

64 7,5 10 12 / 3

7 18 / 3

54 30% .

54 * (7 5,25) = 94,5 94,5/283,5 = 33%

36 * (10 7,5 ) = 90 90/270 = 33%

65 ! 12 / 3 15 / 3

.

(45 * 7 54 * 5,25) = 31,5 / 283,5 = 11,11%

;

66 . !

. !

( )

.

67

; ; ; ; ; ; ;

68: , ,

: ( , , . : ( , )

69:

-

70 4 5 . . o 4-5 . (stent) 8,860e 10,440e. bypass 12,840e 13,373e. 156,4 90 . . 1,79 . . 20% . .

, ,

71 . :

30 .

1 3% . 2 .

.

15 . .

.

(HbA1c 7%) 1570 euro (60% ).

( 50 60% ) 2900 2,3 12 15% .72

2012 7.100 56% - 15% () 500 8% 9% (800 900 ) , 3% 4% .73

, , (analytics) , .

, , .

, , .

74

.

. . , , , , , , .

, .

. , , .

75134254.29819993.012583.8337640.9662538.596819.7248512.5777518.04193066546.65580589195.3136800.96472907.25988.0424967.6338538.52130.6

-

( - . ) - - /REBATE/ 1 1/ 172922.57 2583.83 2 2/ 297511.63 - 3 3/ 3649558.81 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 1 1/ 1 2 2/ 2 - 3 3/ 3 4 4/ 4 5 5 1- 6 2- 7 3 8 - 1 9 - 2 000 - 300 00 0000002583.83000819993.010

6.5 13% 23% 6.5% 13% 23% 6.5% 13% 23% 0%

2012 + 13%67,704.29 16,414.09 84,118.38 13.31%11,195.81 72,922.57 2583.8324,467.50 622.00 0%1072.0523%103,932.05 682.48 104,614.53 6.79%7,102.90 97,511.63 2,137.82 1,547.00 23%5668.036.50%263,536.03 515,899.72 779,435.75 16.66%129,876.94 649,558.81 1,058.71 56,655.00 6.50%79.64REBATE-4,338.26 -4,338.26 16.11% 1,024.95 1,482.00 963,830.40 15.37%148,175.65 819,993.01 5,568.49 13.00 493.49 2,039.59 480.00 180.00 2,410.00 963,830.403.55%34,254.2985.08%819,993.012,583.833.91%37,640.966.49%62,538.590.71%6,819.72 - 34254.29819993.012583.8337640.9662538.596819.7234,254.29 - 819,993.01 2,583.83 37,640.96 - 62,538.59 6,819.72

2013 2013 + 13%77,192.00 26,174.00 103,366.00 22.48%23,232.68 80,133.32 193042,143.00 769.00 0%4612.3223%106,222.00 1,037.44 107,259.44 13.87%14,877.60 92,381.84 4,213.00 1,590.00 23%4439.526.50%277,755.00 491,962.06 769,717.06 21.40%164,714.18 605,002.88 1,289.00 52,123.00 6.50%143.47REBATE-18,582.00 -18,582.00 18.99% 2,001.00 1,500.00 961,760.50 19.16%202,824.46 777,518.04 11,112.65 20.00 1,450.00 1,876.00 510.00 180.00 1,020.00 oaee2,808.00 961,760.505.04%48,512.5080.84%777,518.041,930.006.92%66,546.656.04%58,058.000.96%9,195.3148,512.50777,518.041,930.0066,546.6558,058.009,195.31

363264.7266548.29453019.97

2014

1 201220132014 34,254.29 48512.536800.96819,993.01 777518.04472907.252,583.83 1930988.04- 37,640.96 66546.6524967.63 62,538.59 5805838538.56,819.72 9195.312130.6

1000000000000000000

-

2014 2013 + 13%44,994.72 18,270.00 63,264.72 23.00%14,549.57 48,715.15 988.0416,802.00 184.00 0%31223%65,815.45 732.84 66,548.29 -0.45%-296.23 66,844.52 404.00 1,066.00 23%17306.50%191,813.99 261,205.98 453,019.97 21.12%95,672.39 357,347.58 1,633.17 34,749.04 6.50%88.6REBATE-6,500.00 21.12% 404.56 1,179.00 576,332.98 17.95%109,925.73 472,907.25 4,647.16 20.00 452.74 1,250.00 114.00 90.46 510.00 oaee576,332.986.39%36,800.9682.05%472,907.25988.044.33%24,967.636.69%38,538.500.37%2,130.6036,800.96472,907.25988.0424,967.6338,538.502,130.60